Literature DB >> 11602855

Kidney preservation with university of Wisconsin and Celsior solution: a prospective multicenter randomized study.

A Faenza1, F Catena, B Nardo, R Montalti, E Capocasale, N Busi, U Boggi, F Vistoli, A Di Naro, A Albertazzi, F Mosca, A Cavallari.   

Abstract

BACKGROUND: Although the University of Wisconsin (U.W.) solution continues to be the most commonly used for intra-abdominal organs, a new solution, Celsior, already used for heart and lungs, has been proposed for kidney and liver preservation. The aim of this research was to assess the effect of Celsior as compared with U.W. on immediate graft function and a 2-year follow-up of kidney transplants.
METHODS: A prospective multicenter randomized study was designed to evaluate the efficacy of the Celsior solution in the clinical preservation of the kidney. In this report, we present the data collected as of September 2000. One hundred donors were included in the trial resulting in 187 renal transplants. Ninety-nine kidneys were stored in Celsior solution and 88 in U.W. solution. The groups were comparable with regard to donor and recipient characteristics.
RESULTS: Delayed graft function occurred in 31.3% of the Celsior group and in 33.9% of the U.W. group (P=n.s.). Mean serum creatinine levels and mean daily urinary output were also comparable. Two year graft survival in kidneys preserved with Celsior was 84% as compared with 75% for U.W.-preserved kidneys without any significant statistical difference.
CONCLUSIONS: Our data show that the preservation of kidneys in Celsior solution in a clinical setting is equivalent to that of U.W. solution. When using Celsior during multiple-organ donor harvesting it would be possible to perform an in situ flush of all intra-abdominal and intrathoracic organs with a single cold storage solution.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11602855     DOI: 10.1097/00007890-200110150-00016

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  7 in total

1.  Celsior versus University of Wisconsin preserving solutions for liver transplantation: postreperfusion syndrome and outcome of a 5-year prospective randomized controlled study.

Authors:  Francisco A García-Gil; María T Serrano; Lorena Fuentes-Broto; Juan Arenas; José J García; Antonio Güemes; Vanesa Bernal; Ana Campillo; Carlos Sostres; Juan J Araiz; Pablo Royo; Miguel A Simón
Journal:  World J Surg       Date:  2011-07       Impact factor: 3.352

Review 2.  Preservation solutions used during abdominal transplantation: Current status and outcomes.

Authors:  Nicholas Latchana; Joshua R Peck; Bryan A Whitson; Mitchell L Henry; Elmahdi A Elkhammas; Sylvester M Black
Journal:  World J Transplant       Date:  2015-12-24

3.  Protective effect of zinc-N-acetylcysteine on the rat kidney during cold storage.

Authors:  Mandeep Singh; Dolapo T Odeniyi; Eugene O Apostolov; Alena Savenka; Todd Fite; Grant W Wangila; Richard B Walker; Alexei G Basnakian
Journal:  Am J Physiol Renal Physiol       Date:  2013-07-03

4.  Donor treatment with a PHD-inhibitor activating HIFs prevents graft injury and prolongs survival in an allogenic kidney transplant model.

Authors:  W M Bernhardt; U Gottmann; F Doyon; B Buchholz; V Campean; J Schödel; A Reisenbuechler; S Klaus; M Arend; L Flippin; C Willam; M S Wiesener; B Yard; C Warnecke; K-U Eckardt
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-23       Impact factor: 11.205

5.  Pancreas preservation for pancreas and islet transplantation.

Authors:  Yasuhiro Iwanaga; David Er Sutherland; James V Harmon; Klearchos K Papas
Journal:  Curr Opin Organ Transplant       Date:  2008-08       Impact factor: 2.640

6.  Pancreas procurement and preservation for islet transplantation: personal considerations.

Authors:  Hirofumi Noguchi
Journal:  J Transplant       Date:  2011-09-12

7.  Preservation Solutions for Kidney Transplantation: History, Advances and Mechanisms.

Authors:  Yimeng Chen; Jian Shi; Terry C Xia; Renfang Xu; Xiaozhou He; Ying Xia
Journal:  Cell Transplant       Date:  2019-08-26       Impact factor: 4.064

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.